email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1276 - 1290
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
HutchMed to Raise $600 Million in Hong Kong IPO
$5.00
Available
HuiGene, a Shanghai Gene Editing Company, Closes $62 Million B Round
$5.00
Available
Jacobio Starts Trial of SHP2 Inhibitor, Triggering $20 Million Payment from AbbVie
$5.00
Available
OncoNano Raises $50 Million from China Investor for pH-based Cancer Products
$5.00
Available
Sirnaomics to Start Clinical Trials of RNAi Candidate in China
$5.00
Available
Zai Lab Enters Four-Drug, $1.4 Billion Deal with MacroGenics
$5.00
Available
LinkDoc, a Beijing Cancer Data Company, to Raise up to $500 Million in US IPO
$5.00
Available
Innovent Starts China Trial of Dual Agonist Obesity Treatment
$5.00
Available
Asieris to Start US Combination Trial of MetAP2 Inhibitor for Bladder Cancer
$5.00
Available
HiFiBiO Raises $75 Million for Clinical Trials and Drug Discovery
$5.00
Available
ImmVira Starts China/US Phase II Trial of Oncolytic Virus for Cancer
$5.00
Available
BeiGene Reports BTK Inhibitor Posts Better Results than the Competition
$5.00
Available
CBMG Says Bi-Specific CAR-T Effective in Non-Hodgkin Lymphoma Trial
$5.00
Available
Ascentage Reports Bcl-2 Inhibitor Effective in Early Test
$5.00
Available
CARsgen Therapeutics to Raise $400 Million in Hong Kong IPO
$5.00
Available